Wave Life Sciences WVE
NASDAQ WVE
$3.64 -0.03 (-0.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

Wave Life Sciences (WVE) Research & Development (2014 - 2026)

Updated

Wave Life Sciences (WVE) recorded Research & Development of $51.29 million in Q2 2026, up 18.0% from $43.47 million a year earlier and up 8.1% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Research & Development (2014 - 2026) Analysis & Trends

On a TTM basis, Wave Life Sciences' Research & Development came in at $197.42 million as of Jun 30, 2026, up 16.2% year-over-year; for FY2025, it was $182.78 million, up 14.5% from FY2024.

  • Annual Research & Development has increased for three straight years, with a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $159.68 million in FY2024 (+22.8%), $130.01 million in FY2023 (+12.2%), $115.86 million in FY2022 (-4.9%) and $121.88 million in FY2021 (-6.9%).
  • Quarterly Research & Development has ranged from $25.76 million in Q4 2021 to $52.81 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Research & Development has increased for 15 consecutive quarters, with growth averaging 19.3% over the last eight quarters.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 31.0% in Q4 2024, against a decline of 17.7% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $47.44 million (Q1 2026), $52.81 million (Q4 2025) and $45.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Wave Life Sciences 709.33 Mn -1.00 Bn - 51.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.29 Mn
Mar 31, 2026 47.44 Mn
Dec 31, 2025 52.81 Mn
Sep 30, 2025 45.87 Mn
Jun 30, 2025 43.47 Mn
Mar 31, 2025 40.62 Mn
Dec 31, 2024 44.65 Mn
Sep 30, 2024 41.20 Mn
Jun 30, 2024 40.39 Mn
Mar 31, 2024 33.45 Mn
Dec 31, 2023 34.07 Mn
Sep 30, 2023 31.64 Mn
Jun 30, 2023 33.31 Mn
Mar 31, 2023 30.98 Mn
Dec 31, 2022 31.08 Mn
Sep 30, 2022 27.58 Mn
Jun 30, 2022 29.73 Mn
Mar 31, 2022 27.47 Mn
Dec 31, 2021 25.76 Mn
Sep 30, 2021 31.09 Mn
API Access

Wave Life Sciences Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=WVE&period=max&api_key=YOUR_API_KEY